Ken Mandl Warns of Biomarkup and AI Risks in Healthcare
MY TECH INTERESTS
MY PROFESSION
- Ken Mandl, director of the computational health informatics program at Boston Children’s Hospital, warned about biomarkup, where commercial interests can influence medical measures.1
- Mandl expressed concerns about how artificial intelligence tools could be gamed in the health sector, potentially prioritizing profits over patient care.1
- Ken Mandl, director of the computational health informatics program at Boston Children’s Hospital, warned about biomarkup, where commercial interests can influence medical measures.
- Mandl expressed concerns about how artificial intelligence tools could be gamed in the health sector, potentially prioritizing profits over patient care.